Quetiapine 150 MG Oral Tablet — RxCUI 389201
RxNorm drug concept · Semantic clinical drug
RxCUI 389201
Semantic clinical drug · SCD
● Current RxNorm concept 28 FDA products
106 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI389201
Official nameQuetiapine 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asquetiapine (as quetiapine fumarate) 150 MG Oral Tablet; QUEtiapine fumarate 150 MG Oral Tablet
FDA products mapped28
Package NDCs mapped106
Reported Medicaid activity (SDUD)2,358,317 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Quetiapine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Quetiapine is approved to treat schizophrenia, bipolar disorder (both manic episodes and depressive episodes), and — in the extended-release form only — as an add-on to an antidepr...
- It depends on the form. If you're taking the regular tablet, you can take it with or without food — no restrictions. But if you're on the extended-release tablet, you should take i...
- Does it matter if I take quetiapine with food?
- Sleepiness is actually one of the most common side effects — in some studies, more than half of patients reported it. Quetiapine blocks histamine receptors in the brain, which has...
🕸️ Concept Web — How Quetiapine 150 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Quetiapine 150 MG Oral Tablet
RxCUI 389201 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Quetiapine
51272IN
-
Quetiapine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Quetiapine Oral Tablet
374646SCDF -
Quetiapine Oral Product
1157343SCDG -
Quetiapine Pill
1157344SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Quetiapine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Quetiapine 150 MG
393456SCDC
-
Quetiapine 150 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Quetiapine 150 MG
SCDC · 393456 -
Quetiapine Oral Tablet
SCDF · 374646 -
Quetiapine Oral Product
SCDG · 1157343 -
Quetiapine Pill
SCDG · 1157344
📦 FDA Products & Package NDCs
28 products · 106 package NDCs
106 package NDCs map to RxCUI 389201 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 67877-0247-38 | 10 BLISTER PACK in 1 CARTON (67877-247-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0247-60 | 60 TABLET, FILM COATED in 1 BOTTLE (67877-247-60) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-248-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-248-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-33 | 1 BLISTER PACK in 1 CARTON (67877-248-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-38 | 10 BLISTER PACK in 1 CARTON (67877-248-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-249-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-249-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-33 | 1 BLISTER PACK in 1 CARTON (67877-249-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-38 | 10 BLISTER PACK in 1 CARTON (67877-249-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-250-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-250-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-33 | 1 BLISTER PACK in 1 CARTON (67877-250-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-38 | 10 BLISTER PACK in 1 CARTON (67877-250-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 76420-0512-01 | 100 TABLET, FILM COATED in 1 BOTTLE (76420-512-01) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0512-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-512-10) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0512-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-512-20) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0512-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-512-30) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0512-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-512-60) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0512-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-512-90) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0513-01 | 100 TABLET, FILM COATED in 1 BOTTLE (76420-513-01) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0513-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-513-10) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0513-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-513-20) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0513-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-513-30) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0513-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-513-60) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0513-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-513-90) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0514-01 | 100 TABLET, FILM COATED in 1 BOTTLE (76420-514-01) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0514-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-514-10) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0514-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-514-20) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0514-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-514-30) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0514-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-514-60) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0514-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-514-90) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0516-01 | 100 TABLET, FILM COATED in 1 BOTTLE (76420-516-01) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0516-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-516-10) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0516-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-516-20) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0516-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-516-30) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0516-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-516-60) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0516-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-516-90) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0518-01 | 100 TABLET, FILM COATED in 1 BOTTLE (76420-518-01) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0518-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-518-10) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0518-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-518-20) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0518-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-518-30) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0518-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-518-60) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0518-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-518-90) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0519-01 | 10 BLISTER PACK in 1 CARTON (76420-519-01) / 10 TABLET, FIL... | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0519-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-519-10) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0519-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-519-20) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0519-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-519-30) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0519-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-519-60) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
| 76420-0519-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-519-90) | Quetiapine | ASCLEMED USA INC. | 2025-10-21 |
Observed labelers:
ASCLEMED USA INC. (42) ·
Ascend Laboratories, LLC (27) ·
Aurobindo Pharma Limited (22) ·
Rising Pharma Holdings, Inc. (15)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.